Further, TRIM28 protein showed higher levels in GBM as measured by quantitative proteomics data from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and immunohistochemistry from the Protein atlas (Figure 4—figure supplement 1M and N). This evidence concerns the gene TRIM28 and glioblastoma.